在怀孕期间药物安全性
Debra Kennedy1,2,3, Ronald Batagol1,2,3
1Royal Hospital for Women, Sydney.
Australian prescriber
|March 5, 2025
概括
怀孕期间的药物安全性至关重要,因为暴露时间会影响胎儿的发育. 有限的数据存在,需要对孕妇患者进行仔细的益处风险评估.
科学领域:
- 药理学 药理学是指药理学的学科.
- 产科 产科 产科 产科 产科
- 甲状腺学 甲状腺学
背景情况:
- 怀孕期间接触药物对胎儿发育构成风险.
- 由于试验排除和研究挑战,怀孕期间药物安全性数据有限.
- 要平衡母亲的治疗效益与胎儿的风险是必不可少的.
研究的目的:
- 突出药物暴露时间对胎儿发育的影响.
- 为了解决关于怀孕期间药物安全性的数据短缺的问题.
- 评估现有的怀孕药物分类系统.
主要方法:
- 对有关怀孕期间药物影响的现有文献的综述.
- 分析临床试验和流行病学研究中的挑战.
- 国际药物安全分类系统的比较评估.
主要成果:
- 药物暴露的时间对胎儿的影响至关重要.
- 关于孕产妇和胎儿药物安全性的数据存在重大差距.
- 目前的药物分类系统,如澳大利亚的,有局限性.
结论:
- 个性化利益风险评估对于在怀孕期间处方药物至关重要.
- 需要改善药物安全数据和分类系统.
- 基于证据的资源对医疗保健专业人员和消费者来说至关重要.
更多相关视频
05:25Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
152
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
14.6K
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
217
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
217
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
